DAS28 and SDAI: Composite Disease Activity Measures for Rheumatoid Arthritis
DAS28 (Disease Activity Score in 28 joints) and SDAI (Simplified Disease Activity Index) are validated composite scoring systems used to quantify disease activity in rheumatoid arthritis patients, with both recommended by the American College of Rheumatology for clinical practice. 1
Core Components
DAS28 includes:
- 28 tender joint count (TJC)
- 28 swollen joint count (SJC)
- Patient global assessment (PtGA)
- Acute-phase reactant (ESR or CRP)
- Does NOT include provider global assessment
SDAI includes:
- 28 tender joint count (TJC)
- 28 swollen joint count (SJC)
- Patient global assessment (PtGA)
- Provider global assessment (PrGA) - key difference from DAS28
- C-reactive protein (CRP) level
Calculation Methods
The fundamental difference lies in how scores are calculated: 1
DAS28 uses a complex weighted formula that differentially weights components (tender joints weighted more heavily than swollen joints), requiring a calculator
- DAS28-ESR: 0.56 × √(28TJC) + 0.28 × √(28SJC) + 0.70 × ln(ESR) + 0.014 × PtGA
- DAS28-CRP: 0.56 × √(28TJC) + 0.28 × √(28SJC) + 0.36 × ln(CRP + 1) + 0.014 × PtGA + 0.96
SDAI is a simple numerical sum with equal weighting: 28SJC + 28TJC + PrGA + PtGA + CRP 1
Disease Activity Thresholds
DAS28 (scale 0-9.4):
- Remission: <2.6
- Low disease activity: ≥2.6 to <3.2
- Moderate: ≥3.2 to ≤5.1
- High: >5.1 1
SDAI (scale 0-86):
- Remission: ≤3.3
- Low disease activity: >3.3 to ≤11.0
- Moderate: >11.0 to ≤26
- High: >26 1
Clinical Performance and Key Differences
SDAI is the most sensitive and specific for predicting clinical decisions to change DMARDs, and an SDAI score ≤3.3 is one of two ACR/EULAR-recommended remission definitions for RA clinical trials. 1 Research confirms strong correlation between the measures (Spearman's rho 0.897), though they are not interchangeable 2, 3.
Critical Caveats:
DAS28 is less conservative in defining remission than SDAI - studies show DAS28 identifies an additional 44% of patients as being in remission compared to SDAI 4. This means:
- DAS28 remission criteria may be met despite significant swollen joints remaining
- SDAI and CDAI are more stringent and clinically appropriate for defining true remission 4
The ESR contributes 15% of DAS28-ESR information, creating potential pitfalls 1:
- High ESR states with few active joints may underestimate remission
- Low ESR states may falsely suggest remission despite active synovitis
- Biologic agents targeting specific cytokines differentially affect ESR/CRP, potentially deflating scores artificially
SDAI requires point-of-care CRP results, which creates logistical barriers in smaller practice settings but provides real-time assessment capability 1.
Practical Application
For clinical decision-making:
- Use SDAI when provider global assessment and immediate results are needed (simple addition, no calculator required)
- Use DAS28 when established in your practice workflow but recognize its less conservative remission threshold
- Target DAS28 ≤2.4 for treatment optimization (shown to improve RA outcomes) 1
- Target SDAI ≤3.3 for true remission (ACR/EULAR recommended) 1
Be cautious when DAS28 >3.2 is based solely on subjective parameters (tender joints, patient assessments) without objective findings (swollen joints or elevated CRP), as this may indicate central sensitization, psychological factors, or even misdiagnosis rather than true inflammatory activity 5.